FairScope Lab
EN 繁中 简中

BMY

Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

25.34

PEG Ratio

0.82

Dividend Yield

4.59%

Gross Margin

67.23%

Net Margin

8.69%

Revenue CAGR 3Y

3.11%

ROE

23.52%

ROA

4.82%

Buyback Yield

-0.15%

Current Ratio

1.26

Magic Earn Yield

3.72%

Altman Z-Score

1.45

Fair Value River

Score

Valuation 49
Profitability 38
Growth 10
Health 35
Yield 38
← Back to Dashboard